My clinical training is as an advanced heart failure physician with formal research training in patient oriented translational research. My research program is supported by NIH and investigator-initiated industry sources and uses techniques of both translational and clinical research to further the mechanistic understanding of cardiac-renal interactions, fluid and sodium homeostasis, and diuretic resistance. The primary approach of my current research program is prospective mechanistic human studies in heart failure and kidney disease patients, for which we have established extensive infrastructure. N My lab has extensive expertise in biomarker research has established and maintains an extensive bioassay resource with the capability to determine an extensive range of analytes in human biological samples with complexity ranging from simple serum chemistries to complex analytes such as ultra-trace lithium by inductively coupled plasma mass spectrometry, deuterium concentration by IRMS, high dimension multiplex protein assays, and large and small molecules by liquid chromatography mass spectrometry.
Organization | Role | Date |
---|---|---|
NIH/NHLBI Loan Repayment Program | Reviewer | 2022 - Present |
Journal of The American College of Cardiology Heart Failure | Section Editor of the Kidney in Heart Failure Section | 2022 - Present |
Journal of the Society for Cardiovascular Angiography and Interventions | Editorial Board | 2022 - Present |
3ive Labs, 3ive Labs | Clinical trial steering committee | 2021 - Present |
Lilly, Lilly | Clinical trial steering committee and co-PI | 2021 - Present |
NIH/NHLBI Mentored Patient Oriented Research | Reviewer | 2021 |
Reprieve cardiovascualr, Reprieve Cardiovascular | Clinical trial steering committee | 2020 - Present |
NIH/NHLBI Mentored Patient Oriented Research | Reviewer | 2020 |
NIH//PBKD Special Emphasis Panel Review of Small Business Applications in Kidney-Urologic Diseases | Reviewer | 2020 |
NIH/NHLBI Catalyze Program | Reviewer | 2020 |
Heart Failure Society of America | Reviewer/judge and chair of the 2020 Jay N. Cohn New Investigator Award – Basic Science / Clinical | 2020 |
Boehringer Ingelheim, Boehringer Ingelheim | Empagliflozin Scientific Advisory Board | 2019 - Present |
Cardionomic, Cardionomic | Clinical trial steering comittee | 2019 - Present |